API
GSK icon

Advisor Partners II’s GSK GSK Stock Holding History

Advisor Partners II’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.01M Buy
27,956
+4,766
+21% +$169K 0.04% 484
2023
Q2 		$826K Buy
23,190
+619
+3% +$22.2K 0.04% 446
2023
Q1 		$803K Buy
22,571
+3,886
+21% +$136K 0.04% 405
2022
Q4 		$657K Buy
18,685
+2,382
+15% +$79.3K 0.04% 449
2022
Q3 		$480K Buy
+16,303
New +$618K 0.04% 466

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisor Partners II's GSK Position: Q3 2023 in Review

Advisor Partners II increased its GSK (GSK) stake by 21% in Q3 2023, buying an estimated $169K and bringing the position to 27,956 shares worth $1.01M. The position accounts for 0.04% of the portfolio, ranked #484.

Advisor Partners II first reported a position in GSK in Q3 2022 and has held it in 5 quarters since. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Advisor Partners II held 27,956 shares of GSK worth $1.01M as of Q3 2023.
  • Advisor Partners II bought 4,766 GSK shares in Q3 2023, an estimated $169K.
  • GSK made up 0.04% of Advisor Partners II's portfolio in Q3 2023, its #484 holding.
  • Advisor Partners II first reported a position in GSK in Q3 2022 and has held it in 5 quarters since.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.